Weekly paclitaxel with concurrent intensity-modulated radiotherapy for nasopharyngeal carcinoma: outcomes of a tolerance trial

Ai zheng = Aizheng = Chinese journal of cancer

Volumn 26, Issue 4, 2007, Pages 398-402

  Chen, Chun Yan ^a   Lu, Tai Xiang ^a   Zhao, Chong ^a   Lu, Li Xia ^a   Han, Fei ^a   Sun, Ying ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL;

ADULT; AGED; ARTICLE; BONE TUMOR; CANCER STAGING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG TOLERANCE; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; METASTASIS; MIDDLE AGED; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR; PATHOLOGY; REMISSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUCOSITIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PACLITAXEL; RADIOTHERAPY, INTENSITY-MODULATED; REMISSION INDUCTION;

EID: 70350468638     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)